The name of Gebro Pharma has always been associated with pain relief. The Broschek family, founders of this company, built on the legacy of a long pharmaceutical tradition that began to relieve the pain of thousands of people after World War II. Our origins lie with products for anesthesia and with a dexibuprofen, marketed under the brand Seractil®.
A significant number of patients have to deal with pathologies involving pain. It is estimated that one in six Spanish people (17%) suffer from chronic pain. At Gebro Pharma we treat nearly five million suffering patients. Pain is also one of the main factors that lead patients to consult primary care services.
The pain franchise of Gebro Pharma covers the three stages of the ladder identified by the World Health Organization (WHO) with its products. Feliben® treats severe chronic pain, Diliban® and Paxiflas® treats moderate to severe pain and Seractil® is involved in the treatment of mild pain.
This area represents for us the past, the present and above all the future. The portfolio of products which we have developed and, in some cases, manufactured has been expanding for more than 75 years. With these products we cover the spectrum of different phases of pain that people can feel and improve the range of therapeutic tools available to clinical professionals.
Our commitment to a life without pain is firm and also translates into pharmacological training initiatives and technical skills and knowledge for specialists in this area.